Currently Amgen has more than 400 staff in the UK based in Cambridge and Uxbridge, working in both the commercial and development sections of the company.
Amgen’s entire European clinical development programme is coordinated from the UK and in 2004 this involved more than 5,000 European patients participating in over 50 Amgen clinical studies.
The UK and Ireland commercial team is based in Cambridge with full marketing and sales functions, and supporting departments.
R&D expansion announced
The European clinical programme is currently under rapid development to accommodate Amgen’s pipeline products. In January 2006 Amgen announced plans to expand its Cambridge campus and to create a new Development Centre at Uxbridge. This expansion will almost double Amgen’s current UK-based R&D capacity, creating new job opportunities in all aspects of drug development including clinical research, biostatistics, regulatory affairs, safety, data and project management, as well as in key support functions. The decision confirms the UK as a major worldwide scientific hub for Amgen
